Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.67 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.66 |
| ▸ | OPRD1 | P41143 | 9/20 | 0.56 |
| ▸ | ACHE | P22303 | 3/20 | 0.54 |
| ▸ | P4HB | P07237 | 1/20 | 0.51 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.49 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16225886 | 0.93 | MEN1 (0.79) | CYP2D6CYP19A1MEN1KMT2AOPRD1 | |
| SCHEMBL1138318 | 0.93 | MEN1 (0.79) | CYP2D6CYP19A1MEN1KMT2AOPRD1 | |
| SCHEMBL1138320 | 0.93 | MEN1 (0.79) | CYP2D6CYP19A1MEN1KMT2AOPRD1 | |
| SCHEMBL7427630 | 0.93 | CYP2D6 (0.59) | CYP2D6CYP19A1MEN1KMT2AOPRD1 | |
| SCHEMBL8182035 | 0.91 | CYP2D6 (0.57) | CYP2D6CYP19A1MEN1KMT2AOPRD1 | |
| SCHEMBL11193886 | 0.90 | CYP2D6 (0.56) | CYP2D6CYP19A1MEN1KMT2AOPRD1 | |
| SCHEMBL16226147 | 0.88 | MEN1 (0.67) | CYP2D6CYP19A1MEN1KMT2AOPRD1 | |
| Acetic Acid SCHEMBL27992925 | 0.88 | OPRD1 (0.65) | CYP2D6CYP19A1MEN1KMT2AOPRD1 | |
| SCHEMBL16226307 | 0.87 | OPRD1 (0.63) | CYP2D6CYP19A1MEN1KMT2AOPRD1 | |
| Acetic Acid SCHEMBL27992880 | 0.87 | OPRD1 (0.63) | CYP2D6CYP19A1MEN1KMT2AOPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 652 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120117949-A | Method for directly preparing tertiary amine compound from aromatic aldehyde, ketone and secondary amine | 湖南大学 | 2025-06-10 | — | — | CN | claimed |
| CN-117447690-A | Waterproof locking agent for oil field and synthesis method thereof | 胜利油田物华化工厂 | 2024-01-26 | — | — | CN | claimed |
| CN-110967421-B | Method for detecting related substances of flunarizine hydrochloride preparation | 正大青春宝药业有限公司 | 2022-04-12 | — | — | CN | claimed |
| CN-110967421-A | Method for detecting related substances of flunarizine hydrochloride preparation | 正大青春宝药业有限公司 | 2020-04-07 | — | — | CN | claimed |
| US-20140273458-A1 | Chemical Mechanical Planarization for Tungsten-Containing Substrates | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2014-09-18 | — | — | US | claimed |
| EP-2779217-A2 | Chemical mechanical planarization for tungsten-containing substrates | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2014-09-17 | — | — | EP | claimed |
| US-8835492-B2 | Temperature and pH sensitive block copolymer and polymeric hydrogels using the same | SUNGYUNKWAN UNIVERSITY FOUNDATION FOR CORPORATE COLLABORATION (KR) | 2014-09-16 | — | — | US | claimed |
| US-20100233264-A1 | TEMPERATURE AND pH-SENSITIVE BLOCK COPOLYMER HAVING EXCELLENT SAFTY IN VIVO AND HYDROGEL AND DRUG DELIVERY SYSTEM USING THEREOF | SUNGKYUNKWAN UNIVERSITY FOUNDATION FOR CORPORATE COLLABORATION (KR) | 2010-09-16 | — | — | US | claimed |
| WO-2009031861-A2 | TEMPERATURE AND PH-SENSITIVE BLOCK COPOLYMER HAVING EXCELLENT SAFETY IN VIVO AND HYDROGEL AND DRUG DELIVERY SYSTEM USING THEREOF | SUNGKYUNKWAN UNIVERSITY FOUNDATION FOR CORPORATE COLLABORATION (KR) | 2009-03-12 | — | — | WO | claimed |
| WO-2008155777-A2 | PROCESS FOR PREPARING EFLETRIZINE | CADILA HEALTHCARE LIMITED (IN) | 2008-12-24 | — | — | WO | claimed |
| US-20080293827-A1 | Temperature and Ph Sensitive Block Copolymer and Polymeric Hydrogels Using the Same | SUNGKYUNKWAN UNIVERSITY FOUNDATION FOR COROPORATE COLLABORATION (KR) | 2008-11-27 | — | — | US | claimed |
| EP-0266549-B1 | CINNAMYL AMINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) | 1991-06-19 | — | — | EP | claimed |
| EP-0266549-A1 | Cinnamyl amines, process for their preparation and pharmaceutical compositions containing them | BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) | 1988-05-11 | — | — | EP | claimed |
| EP-0152799-B1 | COMPOUNDS HAVING PERIPHERAL CALCIUM ANTAGONIST, ANTICONVULSIVE AND EUMETABOLIC ACTIVITY, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | PULITZER ITALIANA S.p.A. (IT) | 1987-10-28 | — | — | EP | claimed |
| EP-0152799-A1 | Compounds having peripheral calcium antagonist, anticonvulsive and eumetabolic activity, processes for the preparation thereof and pharmaceutical compositions containing them | PULITZER ITALIANA S.p.A. (IT) | 1985-08-28 | — | — | EP | claimed |
| CN-122059950-A | Compounds with proteasome agonistic activity, preparation method and application thereof | 浙大城市学院 | 2026-05-19 | — | — | CN | disclosed |
| US-20260092134-A1 | Bioreducible Poly (Beta-Amino Ester)s For siRNA Delivery | UNIV JOHNS HOPKINS (US) | 2026-04-02 | — | — | US | disclosed |
| US-4377578-A | ANTIANAPHYLACTIC AGENTS, ANTIHISTAMINES | JANSSEN PHARMACEUTICA, N.V. (BE) | 1983-03-22 | — | — | US | disclosed |
| US-4250176-A | BENZIMIDAZOLE-2-ONE, BENZOTHIAZOL-2-ONE, OR BENZOXAZOL-2-ONE SUBSTITUTIONS, ANTIANAPHALACTIC AGENTS, ANTIHISTAMINES | JANSSEN PHARMACEUTICA N.V. (BE) | 1981-02-10 | — | — | US | disclosed |
| US-4200641-A | ANTIANAPHYLACTIC AGENTS, ANTIHISTAMINES | JANSSEN PHARMACEUTICA, N.V. (BE) | 1980-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100233264-A1 | TEMPERATURE AND pH-SENSITIVE BLOCK COPOLYMER HAVING EXCELLENT SAFTY IN VIVO AND HYDROGEL AND DRUG DELIVERY SYSTEM USING THEREOF | CD44, PSAT1, ALAD | CYP2D6 2707/4885CYP19A1 2439/4885MEN1 4843/4885 |
| US-20080293827-A1 | Temperature and Ph Sensitive Block Copolymer and Polymeric Hydrogels Using the Same | LRBA, DAO, PAM | CYP2D6 2139/4885CYP19A1 3270/4885MEN1 2599/4885 |
| US-20260092134-A1 | Bioreducible Poly (Beta-Amino Ester)s For siRNA Delivery | SLC43A1, SLC7A5, SLC7A1 | CYP2D6 3859/4885CYP19A1 4306/4885MEN1 3141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.